Faculty in the News - Archive
Friday, May 18, 2007Professor Frederick ProvornyThe Montgomery Gazette
– A shareholder has filed a class-action suit in Montgomery County Circuit Court claiming that MedImmune, Inc. violated the law by not seeking the ‘‘highest value reasonably available" when it agreed to sell the Gaithersburg biotech last month to AstraZeneca PLC for $15.2 billion. Such suits are common after corporate takeovers, said Frederick Provorny, JD, visiting professor and director of the Maryland Intellectual Property Legal Resource Center at the School of Law. He speculated that the shareholder may want to "sweeten the pot for shareholders in addition to demanding more information on the deal."
Thursday, May 17, 2007Professor Jana SingerThe Baltimore Sun, The Daily Record
– A baby conceived from an egg donated by one woman and implanted in another may have no mother at all under Maryland law, the state’s highest court ruled yesterday. The court found that paternity laws apply equally to men and women. "It says to me that the court is taking a close look [at the Equal Rights Amendment], for whatever reason, and one might imagine it might be that they are thinking and writing about %85 same-sex marriage," said Jana Singer, JD, a School of Law professor specializing in family and constitutional law.
Wednesday, May 16, 2007Professor Michael GreenbergerWUSA-TV, Ch. 9
– Michael Greenberger, JD, professor at the School of Law and director of the Center for Health and Homeland Security, talked about a report that former U.S. Attorney General John Ashcroft nearly resigned after the White House recertified an anti-terrorism program and how then-White House Counsel Alberto Gonzales made a late-night hospital visit in 2004 to pressure the critically ill Ashcroft to approve the program.
Tuesday, May 15, 2007Professor Michael GreenbergerFinancial Post (Canada)
– Optionable, Inc., the company at the center of Bank of Montreal’s record natural-gas trading losses, plunged further into crisis yesterday after its chief executive unexpectedly quit, and the company’s largest shareholder pulled its representative from the board. The New York Mercantile Exchange (NYMEX), which owns 19 percent of Optionable, said it is concerned about recent developments at Optionable and is "actively reviewing the situation" at the broker. Michael Greenberger, JD, professor at the School of Law and a former director of trading and markets at the U.S. Commodities Futures Trading Commission, said NYMEX’s clear concern about Optionable will push regulators to launch an investigation.
Monday, May 14, 2007Professor Lawrence SungThe Daily Record
– It has been nearly six years since Digene Corp. originally filed suit against Ventana Medical Systems, Inc. for infringement on intellectual property related to Digene’s human papillomavirus testing technology. Most recently, a federal judge ruled against Digene in its quest to obtain a preliminary injunction against Ventana. Such legal wrangling is a normal part of doing business in bioscience, an intellectual property-driven industry, according to patent law experts. "Either you almost have a monopoly position as the only ones who are legally able to practice in that patented field," said Lawrence Sung, JD, PhD, professor and director of the Intellectual Property Law Program at the School of Law, "or you’re in a competitive marketplace where others are paying you some royalty revenue."
Go to page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86